Skip to content

Effects of Phototherapy by Light-emitting Diode Therapy (LEDT) on Clinical, Biochemical and Biomechanical of Muscle Performance in Athletes

Effects of Phototherapy by Light-emitting Diode Therapy (LEDT) on Clinical, Biochemical and Biomechanical of Muscle Performance in Athletes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01770977
Enrollment
45
Registered
2013-01-18
Start date
2012-05-31
Completion date
2012-09-30
Last updated
2013-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athlete

Keywords

Light-emitting diode therapy, Muscle performance, Aerobic performance, Lactate, Creatine kinase

Brief summary

Light-emitting diode Therapy (LEDT) has been used to improve human muscle performance in experimental models and human researches. Now, the investigators used LEDT to increase muscle performance of professional athletes with high performance.

Detailed description

The study assessed muscle performance by vertical jump (height of jump and muscle power); creatine kinase; lactate; metabolism by resonance nuclear magnetic in urine; oxygen uptake (VO2) and its onset kinetic response.

Interventions

DEVICELight-emitting diode therapy

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Centro de Pequisas de Ótica e Fotônica
CollaboratorOTHER
Universidade Federal de Sao Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
14 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* professional athletes aged between 14 and 16 years; * professional athletes aged between 18 and 28 years

Exclusion criteria

* previous injury to the femoral quadriceps or hamstring muscles, * osseous or articular disorder in the lower limbs, * cardiovascular system disorders, * systemic disease.

Design outcomes

Primary

MeasureTime frameDescription
Functional performance6 weeksMuscle performance in vertical jump and running

Secondary

MeasureTime frameDescription
Biochemical analysis1 weekBlood lactate and creatine kinase assessments

Other

MeasureTime frameDescription
Aerobic performance6 weeksoxygen uptake (VO2) and its onset kinetic response.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026